-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US4618741098 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 185M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | nan |
| Dividend Yield | None |
eXoZymes, Inc., a development stage company, focuses on building a technology platform to develop assets that can be reapplied multiple times in various markets with only small changes, while maintaining and capturing new fundamental IP in the application. The company produces chemicals, including pharmaceuticals, fuels, materials, food additives, colors, fragrances, and novel compounds. Its platform also comprises one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was founded in 2014 and is headquartered in Monrovia, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EXOZ using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025